https://www.targetedonc.com/view/sotorasib-reveals-anti-tumor-efficacy-in-kras-g12c-positive-advanced-pancreatic-cancer
New results from the advanced pancreatic cancer cohort of the CodeBreaK 100 trial show positive efficacy and safety.
Create an account or login to join the discussion